Petter Bjornstad, Amy B. Karger, David M. Maahs 

Slides:



Advertisements
Similar presentations
Kidney Involvement in Leukemia and Lymphoma
Advertisements

Chronic Pain in End-Stage Renal Disease
Renal Tubular Acidosis and the Nephrology Teaching Paradigm
Sheldon Chen  Advances in Chronic Kidney Disease 
Frederik Persson, Peter Rossing  Kidney International Supplements 
Estimated Glomerular Filtration Rate From a Panel of Filtration Markers—Hope for Increased Accuracy Beyond Measured Glomerular Filtration Rate?  Lesley.
Diagnosis and Management of Chronic Kidney Disease
Evaluation of Kidney Donors: Core Curriculum 2018
Uric Acid as a Target of Therapy in CKD
Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and.
Manjunath P. Pai  Advances in Chronic Kidney Disease 
Tariq Shafi, Andrew S. Levey  Advances in Chronic Kidney Disease 
Jesse C. Seegmiller, John H. Eckfeldt, John C. Lieske 
Metabolic Complications in Elderly Adults With CKD
Measuring GFR Using the Plasma Clearance of 99mTc-DTPA
A Decade After the KDOQI CKD Guidelines
Longitudinal Estimated GFR Trajectories in Patients With and Without Type 2 Diabetes and Nephropathy  Misghina Weldegiorgis, Dick de Zeeuw, Liang Li,
Kidney Involvement in Leukemia and Lymphoma
W. Greg Miller, Graham R.D. Jones  Advances in Chronic Kidney Disease 
Prehypertension and chronic kidney disease: the ox or the plow?
An Update on Neurocritical Care for the Patient With Kidney Disease
John P. Middleton, Patrick H. Pun  Kidney International 
Proteomics Moves into the Fast Lane
William S. Asch, Margaret J. Bia  Advances in Chronic Kidney Disease 
Chronic Pain in End-Stage Renal Disease
The ESRD Uninsured Matter
On the Waterfront Advances in Chronic Kidney Disease
Joseph A. Vassalotti, MD, Lesley A. Stevens, MD, MS, Andrew S
Yousef Rezaei, MD  American Journal of Kidney Diseases 
Volume 77, Issue 1, Pages 5-6 (January 2010)
How to interpret the eGFR in patients with small body surface area
Dorothea Nitsch, MD, MSc  American Journal of Kidney Diseases 
Set Theory: Nephrology ∩ Urology
Dinna N. Cruz  Advances in Chronic Kidney Disease 
Concordance Between Iothalamate and Iohexol Plasma Clearance
Manjula Kurella Tamura, Kristine Yaffe  Kidney International 
Tariq Shafi, MBBS, MHS, Andrew S. Levey, MD, Lesley A
Prediabetes as a Precursor to Diabetic Kidney Disease
Renal Replacement Therapy in Acute Kidney Injury
Polyunsaturated Fatty Acids and Kidney Disease
Volume 84, Issue 1, Pages (July 2013)
Evaluation of GFR Measurement Method as an Explanation for Differences Among GFR Estimation Equations  Shan-Shan Dai, MMed, Yoshinari Yasuda, MD, Chun-Li.
Resolved: The Case for CKD Clinics
Volume 72, Issue 12, Pages (December 2007)
Evidence and Outcomes in CKD
The Kidney Effects of Hematopoietic Stem Cell Transplantation
Drug Dose Adjustments in Patients With Renal Impairment
A Fundamental Theorem of Telehealth
Tandem mass spectrometry measurements of creatinine in mouse plasma and urine for determining glomerular filtration rate  N. Takahashi, G. Boysen, F.
Linda F. Fried, Trevor J. Orchard, Bertram L. Kasiske 
Daniel L. Landry, DO, FASN  Advances in Chronic Kidney Disease 
Crossing Vessel and Crossroads With Urology
Do CIs Give You Confidence?
KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target    American.
Current Concepts in Hemodialysis Vascular Access Infections
Hans Pottel, Laurence Dubourg, Karolien Goffin, Pierre Delanaye 
Perioperative Acute Kidney Injury
Multidrug-Resistant Organisms Within the Dialysis Population: A Potentially Preventable Perfect Storm  David P. Calfee, MD, MS  American Journal of Kidney.
Blood lead and chronic kidney disease in the general United States population: Results from NHANES III  Paul Muntner, Jiang He, Suma Vupputuri, Josef.
Internet Organ Solicitation, Explained
Patient Safety Issues in CKD: Core Curriculum 2015
Novel Strategies for Immune Monitoring in Kidney Transplant Recipients
Nocturia and Aging: Diagnosis and Treatment
Ann M. O'Hare, MA, MD  American Journal of Kidney Diseases 
Glomerular filtration rate via plasma iohexol disappearance: Pilot study for chronic kidney disease in children  G.J. Schwartz, S. Furth, S.R. Cole, B.
In Reply to ‘Plasma Clearance of Iohexol in Hemodialysis Patients Requires Prolonged Blood Sampling’  Tariq Shafi, MBBS, MHS, Andrew S. Levey, MD, Josef.
Decision-Making in Patients With Cancer and Kidney Disease
Update on Cystatin C: Incorporation Into Clinical Practice
Catheter Type, Placement, and Insertion Techniques for Preventing Catheter-Related Infections in Maintenance Peritoneal Dialysis Patients: Summary of.
Jacob J.E. Koopman, MD, PhD  American Journal of Kidney Diseases 
Presentation transcript:

Measured GFR in Routine Clinical Practice—The Promise of Dried Blood Spots  Petter Bjornstad, Amy B. Karger, David M. Maahs  Advances in Chronic Kidney Disease  Volume 25, Issue 1, Pages 76-83 (January 2018) DOI: 10.1053/j.ackd.2017.09.003 Copyright © 2017 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Comparison between GFR-DBS and GFR by iohexol clearance in plasma, Bland–Altman plots of the mean difference (dashed line), and 95% CI (dotted line) between each DBS by 2-time points and 5-time points minus the gold standard (GFR by iohexol clearance measured in plasma) plotted against the mean of the two measures. Abbreviations: CI, confidence interval; DBS, dried capillary blood spots; GFR, glomerular filtration rate; GFR-DBS, GFR measured in DBS. Figure adapted and modified from Maahs DM, Bushman L, Kerr B, Ellis SL, Pyle L, McFann K, et al. A practical method to measure GFR in people with type 1 diabetes. J Diabetes Complications. 2014; 28(5):667-73. Advances in Chronic Kidney Disease 2018 25, 76-83DOI: (10.1053/j.ackd.2017.09.003) Copyright © 2017 National Kidney Foundation, Inc. Terms and Conditions

Figure 2 Example of GFR-DBS sample collection algorithm. Abbreviations: DBS, dried capillary blood spots; GFR, glomerular filtration rate; GFR-DBS, GFR measured in DBS; HPLC, high-performance liquid chromatography; LC-MS/MS, liquid chromatography tandem mass spectrometry. Advances in Chronic Kidney Disease 2018 25, 76-83DOI: (10.1053/j.ackd.2017.09.003) Copyright © 2017 National Kidney Foundation, Inc. Terms and Conditions

Figure 3 Examples of unacceptable, acceptable, and ideal DBS, The DBS on the left represents an unacceptable spot, due to the small amount of blood, layering and abrasion of the sample which degrades sample quality. The DBS in the center is an acceptable spot for analysis—the blood does not quite reach the edges of the spot, but it is adequate in size to provide reasonably accurate results. The DBS on the right is an example of an ideal blood spot which is uniform in color and touches the edges of the entire circle. Abbreviation: DBS, dried capillary blood spots. Advances in Chronic Kidney Disease 2018 25, 76-83DOI: (10.1053/j.ackd.2017.09.003) Copyright © 2017 National Kidney Foundation, Inc. Terms and Conditions